Cite
MLA Citation
Patrick Blin et al.. “Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.” Stroke, vol. 50, no. 9, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100094374815.0x000021